Cited by 114Garlic and Onion StudiesLipoproteins and Cardiovascular HealthBotanical Studies and Applications

The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease

Open access
Sobenin, Igor A, Pryanishnikov, Valentin V, Kunnova, Lyudmila M, Rabinovich, Yevgeny A, Martirosyan, Danik M, Orekhov, Alexander N·2010·Lipids in Health and Disease

Abstract

The double-blinded placebo-controlled randomized study has been performed in 51 coronary heart disease (CHD) patients to estimate the effects of time-released garlic powder tablets Allicor on the values of 10-year prognostic risk of acute myocardial infarction (fatal and non-fatal) and sudden death, with the respect of secondary CHD prevention. It has been demonstrated that 12-month treatment with Allicor results in the significant decrease of cardiovascular risk by 1.5-fold in men (p < 0.05), and by 1.3-fold in women. The above results were equitable also in terms of relative risks. The main effect that played a role in cardiovascular risk reduction was the decrease in LDL cholesterol by 32.9 mg/dl in men (p < 0.05), and by 27.3 mg/dl in women. Thus, the most significant effects were observed in men, while in women the decrease of cardiovascular risk appeared as a trend that might be due presumably to the insufficient sample size. Since Allicor is the remedy of natural origin, it is safe with the respect to adverse effects and allows even perpetual administration that may be crucial for the secondary prevention of atherosclerotic diseases in CHD patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1476-511x-9-119

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Garlic administration at a dose of 300 and 60 mg/day for 12 months and 12 weeks, respectively, decreased total cholesterol, triglyceride, and LDL while increased HDL in patients.

    “Sobenin et al. [110,111] revealed that garlic administration at a dose of 300 and 60 mg/day for 12 months and 12 weeks, respectively decreased TC, TG, and LDL while increased HDL.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Ackermann RT Garlic shows promise for improving some cardiovascular risk factors Arch Intern Med 2001 161 813 24 10.1001/archinte.161.6.813 11268223 · DOI · Paper page
  2. Assmann G Cullen P Schulte H Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Muenster (PROCAM) study Circulation 2002 105 310 5 10.1161/hc0302.102575 11804985 · DOI · Paper page
  3. Yeh YY Liu L Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies J Nutr 2001 131 989S 93S 11238803

Cited by

Sorted by citations

Authors
Sobenin, I. A., Pryanishnikov, V. V., Kunnova, L. M., Rabinovich, Y. A., Martirosyan, D. M., & Orekhov, A. N.
Affiliations
Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences (RU)
Corresponding author
Sobenin, Igor A
Venue
Lipids in Health and Disease
Published
2010
Volume
9
Issue
1
Pages
119
ISSN
1476-511X (ISSN-L)
OpenAlex
W2028736925
Cited by
114
References
35
Citations by year
2026: 3 · 2025: 9 · 2024: 6 · 2023: 8 · 2022: 13 · 2021: 10 · 2020: 6 · 2019: 7 · 2018: 8 · 2017: 2 · 2016: 9 · 2015: 9 · 2014: 7 · 2013: 7 · 2012: 5
FWCI
6.52
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Lipids in Health and Disease (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Garlic and Onion Studies
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Botanical Studies and Applications
Keywords
coronary artery disease, cardiovascular risk, secondary prevention, acute myocardial infarction, sudden death, LDL cholesterol, sex differences, atherosclerosis
MeSH terms
Adult, Aged, Antioxidants, Coronary Artery Disease, Double-Blind Method, Female, Garlic, Humans, Cholesterol, LDL, Male, Middle Aged, Sex Factors, Tablets, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review